CLYM earnings: a positive outcome, +12.3%

On August 6, 2026, Climb Bio, Inc. reached its earnings. The result was a positive outcome, and the stock moved +12.3% in the window around the event. It had already run -12.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.